middle.news
Imugene Raises $11.1 Million to Advance Azer-cel After Positive Clinical Signals
9:49am on Tuesday 7th of July, 2026 AEST
•
Biotechnology
Read Story
Imugene Raises $11.1 Million to Advance Azer-cel After Positive Clinical Signals
9:49am on Tuesday 7th of July, 2026 AEST
Key Points
Placement raises $11.12 million at $0.095 per share
Strong institutional support including global pharma participant
Early Phase 1b data shows 2/2 complete responses in BTKi combination cohort
Funds to support clinical trials, regulatory milestones, and manufacturing
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imugene (ASX:IMU)
OPEN ARTICLE